Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

TVTXTVTX
23 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in TRAVERE THERAPEUTICS INC

GEODE CAPITAL MANAGEMENT, LLC holds 2.4M shares of TVTX (TRAVERE THERAPEUTICS INC), worth $134.8M as of 2026-Q2. The position was increased (+0.1% shares). TVTX represents 0.0% of GEODE CAPITAL MANAGEMENT, LLC's portfolio.

Current Value

$134.8M

Current Shares

2.4M

Total Value Change

+$114.1M

Total Shares Change

+1.6M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.4M
+0.1%
$134.8M0.0%$56.81
30
2026-Q1
Increased
2.4M
+10.6%
$70.4M0.0%$28.27
33
2025-Q4
Increased
2.1M
+0.3%
$81.9M0.0%$37.68
30
2025-Q3
Increased
2.1M
+6.7%
$51.1M0.0%$24.04
31
2025-Q2
Increased
2M
+1.4%
$29.7M0.0%$14.77
29
2025-Q1
Increased
2M
+7.3%
$35.4M0.0%$19.68
31
2024-Q4
Increased
1.8M
+6.4%
$32.1M0.0%$17.32
31
2024-Q3
Increased
1.7M
+3.9%
$24.2M0.0%$14.01
30
2024-Q2
Increased
1.7M
+6.8%
$13.7M0.0%$8.22
30
2024-Q1
Increased
1.6M
+2.6%
$12M0.0%$7.71
29
2023-Q4
Increased
1.5M
+5.6%
$13.7M0.0%$8.99
30
2023-Q3
Increased
1.4M
+3.5%
$12.9M0.0%$8.94
29
2023-Q2
Increased
1.4M
+14.4%
$21.4M0.0%$15.30
32
2023-Q1
Increased
1.2M
+10.9%
$27.4M0.0%$22.09
32
2022-Q4
Increased
1.1M
+3.5%
$23.1M0.0%$21.03
30
2022-Q3
Increased
1.1M
+3.5%
$26.1M0.0%$24.64
30
2022-Q2
Decreased
1M
-3.2%
$24.8M0.0%$24.68
0
2022-Q1
Increased
1.1M
+1.5%
$27.3M0.0%$25.11
29
2021-Q4
Increased
1M
+6.0%
$32.4M0.0%$30.31
31
2021-Q3
Decreased
983,978
-2.1%
$23.9M0.0%$23.99
0
2021-Q2
Increased
1M
+5.0%
$14.7M0.0%$14.95
30
2021-Q1
Increased
957,246
+26.3%
$23.9M0.0%$24.32
35
2020-Q4
New
757,861
-
$20.7M0.0%$27.57
39

Other major holders of TVTX: BlackRock, Inc., FMR LLC, Janus Henderson Group Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used